Long Focus Capital Management, LLC Anixa Biosciences Inc Transaction History
Long Focus Capital Management, LLC
- $2.94 Billion
- Q4 2024
A detailed history of Long Focus Capital Management, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 147,360 shares of ANIX stock, worth $474,499. This represents 0.01% of its overall portfolio holdings.
Number of Shares
147,360
Previous 165,701
11.07%
Holding current value
$474,499
Previous $521,000
29.94%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ANIX
# of Institutions
62Shares Held
5.73MCall Options Held
7.1KPut Options Held
26.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.49 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.16 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$2 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.72 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.51 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $98.7M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...